HomeCLYM • NASDAQ
add
Climb Bio Inc
Previous close
$3.04
Day range
$3.02 - $3.23
Year range
$2.35 - $11.55
Market cap
217.17M USD
Avg Volume
317.60K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 8.39M | 308.07% |
Net income | -8.90M | -124.17% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 193.35M | 79.97% |
Total assets | 222.20M | 97.10% |
Total liabilities | 3.42M | 14.37% |
Total equity | 218.78M | — |
Shares outstanding | 67.22M | — |
Price to book | 0.94 | — |
Return on assets | -9.36% | — |
Return on capital | -9.51% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -8.90M | -124.17% |
Cash from operations | -7.56M | -316.48% |
Cash from investing | -71.79M | -356.05% |
Cash from financing | 2.27M | 330.11% |
Net change in cash | -76.96M | -340.07% |
Free cash flow | -4.00M | -174.86% |
About
Founded
2018
Headquarters
Website
Employees
10
